← Evidence map

ArticleCancer cell2021

Lorlatinib in ALK-Rearranged Lung Cancer.

Shelley Kuang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2021
2022
2023
2024
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 33434512